Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model
Crossref DOI link: https://doi.org/10.1007/s11307-015-0832-x
Published Online: 2015-04-10
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baldoni, Daniela
Waibel, Robert
Bläuenstein, Peter
Galli, Filippo
Iodice, Violetta
Signore, Alberto
Schibli, Roger
Trampuz, Andrej
License valid from 2015-04-10